Literature DB >> 7679905

Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.

K Blennow1, A Wallin, C G Gottfries, J E Månsson, L Svennerholm.   

Abstract

Concentration gradients in lumbar cerebrospinal fluid (CSF) for the monoamine metabolites homovanillic acid (HVA), 5-hydroxy-indoleacetic acid (5-HIAA) and 4-hydroxy-3-methoxyphenylglycol (HMPG) were studied in 9 healthy controls and 47 neuropsychiatric patients without diseases causing disturbed CSF circulation. In a serial sampling of the first 24 ml of CSF, steep concentration gradients between the first (0-4th ml) and last (21st-24th ml) portions of CSF were found for HVA (99 +/- 59% increase; p < 0.001) and 5-HIAA (88 +/- 54% increase; p < 0.001), while the concentration gradient was slight for HMPG (11 +/- 7% increase; p < 0.001). The existence of marked concentration gradients for the monoamine metabolites HVA and 5-HIAA gives further evidence for an active transport system for these metabolites and indicates that the lumbar CSF-HVA and 5-HIAA levels reflect the dopamine and serotonin metabolism in the brain. Moreover, the existence of pronounced concentration gradients for HVA and 5-HIAA stresses the importance of making analyses on a standardized volume of CSF.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679905     DOI: 10.1007/bf02260910

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  9 in total

1.  Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid.

Authors:  W Maruyama; H Narabayashi; P Dostert; M Naoi
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy.

Authors:  M Tullberg; J E Månsson; P Fredman; A Lekman; K Blennow; R Ekman; L E Rosengren; M Tisell; C Wikkelsø
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

3.  Effects of clozapine on CSF homovanillic acid in spasmodic torticollis.

Authors:  A Thiel; D Dressler; A Reimer; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1994

4.  Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.

Authors:  Maria Bjerke; Erik Portelius; Lennart Minthon; Anders Wallin; Henrik Anckarsäter; Rolf Anckarsäter; Niels Andreasen; Henrik Zetterberg; Ulf Andreasson; Kaj Blennow
Journal:  Int J Alzheimers Dis       Date:  2010-07-15

Review 5.  Oscillatory serotonin function in depression.

Authors:  Ronald M Salomon; Ronald L Cowan
Journal:  Synapse       Date:  2013-05-21       Impact factor: 2.562

Review 6.  A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Sun Ah Park; Ju Hee Kang; Eun Suk Kang; Chang Seok Ki; Jee Hoon Roh; Young Chul Youn; Seong Yoon Kim; Sang Yun Kim
Journal:  J Clin Neurol       Date:  2015-04       Impact factor: 3.077

7.  Towards a unified protocol for handling of CSF before β-amyloid measurements.

Authors:  Shorena Janelidze; Erik Stomrud; Britta Brix; Oskar Hansson
Journal:  Alzheimers Res Ther       Date:  2019-07-19       Impact factor: 6.982

8.  Central nervous system monoaminergic activity in hip osteoarthritis patients with disabling pain: associations with pain severity and central sensitization.

Authors:  Martin F Bjurström; Kaj Blennow; Henrik Zetterberg; Mikael Bodelsson; Markus Waldén; Nicholas Dietz; Sara Hall; Oskar Hansson; Michael R Irwin; Niklas Mattsson-Carlgren
Journal:  Pain Rep       Date:  2022-01-24

9.  Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus.

Authors:  Mats Tullberg; Kaj Blennow; Jan-Eric Månsson; Pam Fredman; Magnus Tisell; Carsten Wikkelsö
Journal:  Cerebrospinal Fluid Res       Date:  2008-04-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.